SCHEMBL5226039

SCHEMBL5226039

COc1ccc2c(c1)C1(C)C(C)CCC(C)(C(=O)O)C1CC2=NN1CCN(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLA1 P09884 2/20 0.46
HSD11B1 P28845 3/20 0.36
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
OPRK1 P41145 2/20 0.34
OPRM1 P35372 2/20 0.33
LMNA P02545 1/20 0.33
MDM2 Q00987 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TSHR P16473 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
GRIN2D O15399 3/20 0.32
GRIN3B O60391 3/20 0.32
GRIN1 Q05586 3/20 0.32
GRIN2A Q12879 3/20 0.32
GRIN2B Q13224 3/20 0.32
GRIN2C Q14957 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL443967 0.76 POLA1 (0.48) POLA1HSD11B1NR1H2NR1H3KMT2A
SCHEMBL5510769 0.63 POLA1 (1.00) POLA1NR1H2NR1H3OPRK1TSHR
SCHEMBL12872352 0.63 POLA1 (1.00) POLA1NR1H2NR1H3OPRK1TSHR
SCHEMBL280198 0.63 POLA1 (1.00) POLA1NR1H2NR1H3OPRK1TSHR
SCHEMBL445153 0.61 CYP3A4 (0.51) POLA1NR1H2NR1H3KMT2ATSHR
SCHEMBL445154 0.61 CYP3A4 (0.51) POLA1NR1H2NR1H3KMT2ATSHR
SCHEMBL17252006 0.61 HSD11B1 (0.54) HSD11B1OPRK1OPRM1LMNATSHR
SCHEMBL15706482 0.61 HSD11B1 (0.54) HSD11B1OPRK1OPRM1LMNATSHR
SCHEMBL20245506 0.59 HSD11B1 (0.55) HSD11B1OPRK1OPRM1LMNATSHR
SCHEMBL18634018 0.58 HSD11B1 (0.48) POLA1HSD11B1TSHRCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951748-A2 HEPATITIS C VIRUS VARIANTS Vertex Pharmaceuticals, Inc. (US) 2008-08-06 EP disclosed
WO-2007059221-A9 HEPATITIS C VIRUS VARIANTS VERTEX PHARMA (US) 2007-08-23 WO disclosed
WO-2007059221-A2 HEPATITIS C VIRUS VARIANTS VERTEX PHARMACEUTICALS, INC (US) 2007-05-24 WO disclosed